US Stock Futures Slide as Oil Surge on USIran Tensions Nvidia Earnings in Focus US Economy Shows Solid Q1 Growth Amid Onset of Iran Conflict Inflation Projected to Reach 6 in Second Quarter Top Forecasters Warn Evercore ISI Lifts Seagate Price Target Citing Sector Tailwinds What Amer Realty ARLs 145 Jump Means for Investors 20260515 Consensus CCSI Slides 228 as Selling Pressure Mounts 20260517 Markets Raise Chances for a Fed Rate Hike Following Hot Inflation Report Markets Adjust Rate Hike Expectations as Inflation Data Surprises CVU Q1 2021 Earnings EPS Surpasses Estimates by 414 as Contractor Delivers Profit Beat ITT ITT Delivers Q1 2026 Beat EPS 198 vs 176 Expected Donnelley Financial Solutions Announces 150 Million Share Buyback as Software Revenue Grows CAVA Group Raises 2026 Outlook After Strong FirstQuarter Results Shares Surge Global Markets Rally as Iran Peace Hopes Boost Risk Appetite Oil and Dollar Slide SEC Updates IPO Regulatory Framework What Market Participants Should Know PutinXi Talks to Address Stalled Power of Siberia 2 Pipeline Amid Energy Market Turmoil Spelling Bee Coach Scott Remer Building a Business From Competitive Education Michael Saylor Tokenization Could Create a Free Market in Credit and Yield Challenging Traditional Banking Pet Supplies Retailer Files Chapter 11 Bankruptcy Amid Industry Challenges HPQ Q1 2026 Earnings EPS Beats Estimates as Stock Surges CAPL Q1 2026 Earnings Strong Earnings Beat Driven by Operational Efficiencies Americold Realty Trust COLD Q1 2026 Earnings NarrowerThanExpected Loss Lifts Sentiment Modular Medical Q3 2025 Earnings Deeperthanexpected loss as stock rises 458 OLED Q1 2026 Earnings Major EPS Miss Raises Concerns Amidst Growth Expectations TopBuild Corp BLD Holds Steady Near Key Support as Volume Patterns Shift Invesco Municipal Trust VKQ Holds Steady Near 971 as Investors Assess Yield and Rate Outlook QVCD Holds Steady at 1010 Amid Flat Trading Support and Resistance Levels in Focus Catalyst Pharmaceuticals CPRX Holds Steady Near Support as Volume Remains Subdued Milestone Pharmaceuticals MIST Q1 2026 Earnings Significant EPS Miss as PreRevenue Biotech Continues Pipeline Development